Mar 20 2015, 08:54 ET | By: Douglas W. House, SA News Editor Contact this editor with comments or a news tip In a direct offering to institutional investors, OXiGENE (NASDAQ:OXGN) sells $10M of common stock at $1.7125 per share plus a warrant to purchase one half share of common stock at $1.7125 for a five-year term. Closing date is March 25.Net proceeds will fund the advancement of fosbretabulin, OXi4503 and general corporate purposes.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.